China's Innovative Turn and the Changing Pharmaceutical Landscape.
- Published in:
- University of the Pacific Law Review, 2020, v. 51, n. 3, p. 593
- By:
- Publication type:
- Article
Works matching IS 23794895 AND DT 2020 AND VI 51 AND IP 3
Results: 7
1
2
Congress Should Decline Ill-Advised Legislative Proposals Aimed at Evergreening of Pharmaceutical Patent Protection.
- Published in:
- University of the Pacific Law Review, 2020, v. 51, n. 3, p. 493
- By:
- Publication type:
- Article
3
The Pharmaceutical Industry's Corrupt Price Discrimination System: A Single Solution?
- Published in:
- University of the Pacific Law Review, 2020, v. 51, n. 3, p. 475
- By:
- Publication type:
- Article
4
WTO Law and Prices of Pharmaceutical Products: Rule of Law Gaps and the Unclear Balance between Trade Protection, Human Rights, and IP Protection.
- Published in:
- University of the Pacific Law Review, 2020, v. 51, n. 3, p. 451
- By:
- Publication type:
- Article
5
Note from the Chief Technical Editor.
- Published in:
- University of the Pacific Law Review, 2020, v. 51, n. 3, p. 447
- By:
- Publication type:
- Article
6
Introduction: Changing Regulation of Pharmaceuticals: Issues in Pricing, Intellectual Property, Trade and Ethics.
- Published in:
- University of the Pacific Law Review, 2020, v. 51, n. 3, p. 447
- By:
- Publication type:
- Article
7
Note from the Chief Comment Editor.
- Published in:
- University of the Pacific Law Review, 2020, v. 51, n. 3, p. 446
- By:
- Publication type:
- Article